Literature DB >> 35510509

Time to Clearance of Neisseria gonorrhoeae RNA at the Pharynx following Treatment.

Lindley A Barbee1,2, Olusegun O Soge1,3, Christine M Khosropour4, Angela LeClair1, Matthew R Golden1,2,4.   

Abstract

The number of days until pharyngeal Neisseria gonorrhoeae nucleic acid amplification test (NAAT) results become negative after treatment remains unknown. Between March 2019 and April 2021, we enrolled men who have sex with men (MSM) who had a clinical positive pharyngeal N. gonorrhoeae Aptima Combo 2 test result but had not yet been treated in a prospective longitudinal cohort study. MSM were enrolled on their day of treatment and self-collected daily pharyngeal specimens for 21 days at home. We used Kaplan-Meier estimates to determine the median time to clearance and the >95% time to clearance and the log rank test for equality to evaluate factors associated with time to clearance. Sixty-four men were enrolled in the study. Analyses excluded 8 men (12.5%) who were N. gonorrhoeae negative by NAAT at enrollment and 11 (17%) who failed to return any home-collected specimens. Among the 45 men included in the analysis, the median time to N. gonorrhoeae NAAT clearance was 3 days (95% confidence interval [CI], 2 to 5 days). Time to clearance for >95% of the cohort was 12 days (95% CI, 10 days to an undefined time). Men with a history of N. gonorrhoeae infection cleared faster than men without such history (8 days versus 17 days for >95% time to clearance; P = 0.03). In the absence of reexposure, positive N. gonorrhoeae Aptima Combo 2 assay results obtained prior to 12 days after treatment are likely false-positive results.

Entities:  

Keywords:  NAAT; Neisseria gonorrhoeae; clearance

Mesh:

Substances:

Year:  2022        PMID: 35510509      PMCID: PMC9199414          DOI: 10.1128/jcm.00399-22

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   11.677


  21 in total

1.  Development of New Antimicrobials for Urogenital Gonorrhea Therapy: Clinical Trial Design Considerations.

Authors:  Edward W Hook; Lori Newman; George Drusano; Scott Evans; H Hunter Handsfield; Ann E Jerse; Fabian Y S Kong; Jeannette Y Lee; Stephanie N Taylor; Carolyn Deal
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

2.  Frequency of Nucleic Acid Amplification Test Positivity Among Men Who Have Sex With Men Returning for a Test-of-Cure Visit 7 to 30 Days After Treatment of Laboratory-Confirmed Neisseria gonorrhoeae Infection at 2 Public Sexual Health Clinics, New York City, 2013 to 2016.

Authors:  Ebiere Okah; Emily F Westheimer; Kelly Jamison; Julia A Schillinger
Journal:  Sex Transm Dis       Date:  2018-03       Impact factor: 2.830

3.  Oropharyngeal and Genital Gonorrhea Infections Among Women and Heterosexual Men Reporting Sexual Contact With Partners With Gonorrhea: Implication for Oropharyngeal Testing of Heterosexual Gonorrhea Contacts.

Authors:  Eric P F Chow; Marcus Y Chen; Deborah A Williamson; Catriona S Bradshaw; Lenka A Vodstrcil; Sabrina Trumpour; Benjamin P Howden; Christopher K Fairley
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

4.  Sexually Transmitted Infections Treatment Guidelines, 2021.

Authors:  Kimberly A Workowski; Laura H Bachmann; Philip A Chan; Christine M Johnston; Christina A Muzny; Ina Park; Hilary Reno; Jonathan M Zenilman; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2021-07-23

5.  Evaluation of gonorrhea test of cure at 1 week in a Los Angeles community-based clinic serving men who have sex with men.

Authors:  Matthew R Beymer; Eloisa Llata; Ali M Stirland; Hillard S Weinstock; Christine L Wigen; Sarah L Guerry; Everardo Mejia; Robert K Bolan
Journal:  Sex Transm Dis       Date:  2014-10       Impact factor: 2.830

6.  Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial.

Authors:  Julia C Dombrowski; Michael R Wierzbicki; Lori M Newman; Jonathan A Powell; Ashley Miller; Dwyn Dithmer; Olusegun O Soge; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2021-09-07       Impact factor: 9.079

7.  Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.

Authors:  I Putu Yuda Hananta; Henry John Christiaan De Vries; Alje P van Dam; Martijn Sebastiaan van Rooijen; Hardyanto Soebono; Maarten Franciscus Schim van der Loeff
Journal:  Sex Transm Infect       Date:  2017-08-19       Impact factor: 3.519

Review 8.  Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.

Authors:  Philip A Chan; Ashley Robinette; Madeline Montgomery; Alexi Almonte; Susan Cu-Uvin; John R Lonks; Kimberle C Chapin; Erna M Kojic; Erica J Hardy
Journal:  Infect Dis Obstet Gynecol       Date:  2016-06-05

9.  Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.

Authors:  Jonathan D C Ross; Clare Brittain; Michelle Cole; Claire Dewsnap; Jan Harding; Trish Hepburn; Louise Jackson; Matthew Keogh; Tessa Lawrence; Alan A Montgomery; Tracy E Roberts; Kirsty Sprange; Wei Tan; Sukhwinder Thandi; John White; Janet Wilson; Lelia Duley
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.